XML 38 R27.htm IDEA: XBRL DOCUMENT v3.22.1
Commitments (Tables)
3 Months Ended
Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Manufacturing Commitments and Contingencies

The following table summarizes manufacturing commitments and contingencies as of the period indicated (in thousands):

 

 

March 31, 2022

 

Molgramostim manufacturer:

 

 

 

Achievement of certain milestones related to validation of API and regulatory approval of
    molgramostim

 

$

2,600

 

Molgramostim nebulizer manufacturer:

 

 

 

Achievement of various development activities and regulatory approval of nebulizer utilized
    to administer molgramostim

 

 

556

 

Total manufacturing and other commitments

 

$

3,156